Search
Product
About us
Contact
Blog

DINTO

Other names: DINTO

Names

More detailed information about this field from each metasource.

The Drug-Drug Interactions Ontology

metasource: Fairsharing.org
version: FAIRsharing.org: DINTO; The Drug-Drug Interactions Ontology; DOI: https://doi.org/10.25504/FAIRsharing.dgh9j9; Last edited: Jan. 8, 2019, 1:40 p.m.; Last accessed: Jan 03 2022 7:12 p.m.

metasource: Biontology / Bioportal
version: 1.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/DINTO

DINTO

DINTO is an OWL ontology that systematically organizes all drug-drug interaction (DDI) related information. Drug-drug interactions (DDIs) form a significant risk group for adverse effects associated with pharmaceutical treatment. These interactions are often reported in the literature, however, they are sparsely represented in machine-readable resources, such as online databases, thesauri or ontologies. DINTO is an ontology that describes and categorizes DDIs and all the possible mechanisms that can lead to them (including both pharmacodynamic and pharmacokinetic DDI mechanisms).

Description

More detailed information about this field from each metasource.

DINTO is an OWL ontology that systematically organizes all drug-drug interaction (DDI) related information. Drug-drug interactions (DDIs) form a significant risk group for adverse effects associated with pharmaceutical treatment. These interactions are often reported in the literature, however, they are sparsely represented in machine-readable resources, such as online databases, thesauri or ontologies. DINTO is an ontology that describes and categorizes DDIs and all the possible mechanisms that can lead to them (including both pharmacodynamic and pharmacokinetic DDI mechanisms).

metasource: Biontology / Bioportal
version: 1.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/DINTO

Webpage:

https://code.google.com/p/dinto/

Webpage

More detailed information about this field from each metasource.

https://code.google.com/p/dinto/

http://labda.inf.uc3m.es/doku.php?id=es:labda_dinto

metasource: Biontology / Bioportal
version: 1.3 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/DINTO

More to explore:

1/20

Cancer Drug Interactions

Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported ...

The Potential Drug-drug Interaction and Potential Drug-drug Interaction Evidence Ontology

A domain ontology for potential drug-drug interactions (PDDIs) that covers the material entities and processes in the domain of discourse for PDDI evidence and knowledge claims. The representation ena ...

HIV Drug Interactions

Around 37 million individuals are living worldwide with HIV and although advances in therapy have yielded effective regimens, individual antiretroviral drugs are amongst the most therapeutically risky ...

HEP Drug Interactions

Currently 170 million people worldwide are infected with the hepatitis C virus (HCV) and >300 million with hepatitis B (HBV). Although interferon-free combination direct acting antivirals (DAAs) regim ...

COVID-19 Drug Interactions

The Liverpool Drug Interaction Group (based at the University of Liverpool, UK), in collaboration with the University Hospital of Basel (Switzerland) and Radboud UMC (Netherlands), have produced vario ...

Ontology for Drug Discovery Investigations

The goal of DDI project is to develop an ontology for the description of drug discovery investigations. The Pharmaceutical industry is an information based industry. The aim of DDI is to add value to ...

The Drug Ontology

An ontology of drug products and packaged drug products.

SuperTarget

Drug-related information: medical indications, adverse drug effects, drug metabolism and Gene Ontology terms of the target proteins.

Minimum PDDI Information Ontology

MPIO (Minimum PDDI Information Ontology) is an OWL representation of minimum information regarding potential drug-drug interaction information. It is based on and meant to be use in alignment with DID ...

Veterans Health Administration National Drug File

Veterans Health Administration National Drug File is a centrally maintained electronic drug list used by the VHA hospitals and clinics. Facilities use the NDF to check drug interactions, to manage ord ...

Ontology of Drug Neuropathy Adverse Events

The Ontology of Drug Neuropathy Adverse Events (ODNAE) is an extension of OAE which serves as a knowledge base comprising drug components, chemical entities of active drug ingredients, drug mechanisms ...

Data Documentation Initiative Controlled Vocabularies

The Data Documentation Initiative (DDI) Controlled Vocabularies Group (CVG) has created a set of controlled vocabularies (CVs) that can be used with DDI as well as for other purposes and applications. ...

Uniprot Core Ontology

The UniProt core is an OWL ontology that describes the predicates, classes and concepts used to model the UniProt data in RDF.

DrugCentral

DrugCentral is online drug information that provides information on active ingredients, chemical entities, pharmaceutical products, drug mode of action, indications, and pharmacologic mode of action. ...

Data Documentation Initiative Codebook

Data Documentation Initiative (DDI-Codebook, DDI-C) is a more light-weight version of DDI-Lifecycle, intended primarily to document simple survey data. Originally DTD-based, DDI-C is now available as ...

Data Documentation Initiative Lifecycle

Data Documentation Initiative (DDI) Lifecycle (DDI-Lifecycle, DDI-L) is designed to document and manage data across the entire life cycle, from conceptualization to data publication, analysis and beyo ...

TTD, Therapeutic Target Database

The Therapeutic Target Database provides information about therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these ...

SuperDRUG2 - A One Stop Resource for Approved/Marketed Drugs

SuperDRUG2, an update of the previous SuperDrug database, is a unique, one-stop resource for approved/marketed drugs, containing more than 4,600 active pharmaceutical ingredients. Drugs are annotated ...

DrugBank

The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information.

Pharmacogenomics Knowledge Base

PharmGKB is a resource that provides information about how human genetic variation affects response to medications. PharmGKB collects, curates and disseminates knowledge about clinically actionable ge ...

Previous Next

Need help integrating and/or managing biomedical data?

Follow our Twitter for updates

Service status

Reach us:
[email protected]

Data is amalgamated and only retrieved periodically.
Some of the resources used by the system:

® FAIRsharing.org
® Bioontology/Bioportal Terms
® Nucleic Acid Research - Database
® re3data.org
® bio.tools
® PubMed - Courtesy of the U.S. National Library of Medicine